PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Chemistry, McGill University, 801 Sherbrooke St W, Montreal, QC, Canada, H3A 0B8.\', \'Department of Biochemistry, McGill University, 3649 Promenade Sir William Osler Montreal, QC, Canada, H3G 0B1.\', \'Department of Chemistry, McGill University, 801 Sherbrooke St W, Montreal, QC, Canada, H3A 0B8. Electronic address: anthony.mittermaier@mcgill.ca.\', \'Department of Chemistry, McGill University, 801 Sherbrooke St W, Montreal, QC, Canada, H3A 0B8. Electronic address: nicolas.moitessier@mcgill.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0223-5234(21)00895-310.1016/j.ejmech.2021.114046
?:doi
?:hasPublicationType
?:journal
  • European journal of medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 34995923
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.266
?:rankingScore_hIndex
  • 127
is ?:relation_isRelatedTo_publication of
?:title
  • Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all